Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pramipexole 88microgram tablets
0409010W0AAACAC
|
Pramipexole | Pramipexole | Central Nervous System | 57,415 |
|
Pramipexole 180microgram tablets
0409010W0AAABAB
|
Pramipexole | Pramipexole | Central Nervous System | 24,245 |
|
Pramipexole 350microgram tablets
0409010W0AAADAD
|
Pramipexole | Pramipexole | Central Nervous System | 10,013 |
|
Pramipexole 260microgram modified-release tablets
0409010W0AAAEAE
|
Pramipexole | Pramipexole | Central Nervous System | 4,209 |
|
Pramipexole 520microgram modified-release tablets
0409010W0AAAFAF
|
Pramipexole | Pramipexole | Central Nervous System | 3,850 |
|
Pramipexole 700microgram tablets
0409010W0AAAAAA
|
Pramipexole | Pramipexole | Central Nervous System | 3,224 |
|
Pramipexole 1.05mg modified-release tablets
0409010W0AAAGAG
|
Pramipexole | Pramipexole | Central Nervous System | 2,496 |
|
Pipexus 0.26mg modified-release tablets
0409010W0BEAAAE
|
Pipexus | Pramipexole | Central Nervous System | 1,776 |
|
Pipexus 0.52mg modified-release tablets
0409010W0BEABAF
|
Pipexus | Pramipexole | Central Nervous System | 1,602 |
|
Pramipexole 1.57mg modified-release tablets
0409010W0AAAJAJ
|
Pramipexole | Pramipexole | Central Nervous System | 1,437 |
|
Pipexus 1.05mg modified-release tablets
0409010W0BEADAG
|
Pipexus | Pramipexole | Central Nervous System | 1,287 |
|
Pramipexole 2.1mg modified-release tablets
0409010W0AAAHAH
|
Pramipexole | Pramipexole | Central Nervous System | 1,287 |
|
Pipexus 1.57mg modified-release tablets
0409010W0BEAEAJ
|
Pipexus | Pramipexole | Central Nervous System | 1,044 |
|
Pipexus 2.1mg modified-release tablets
0409010W0BEACAH
|
Pipexus | Pramipexole | Central Nervous System | 930 |
|
Pramipexole 3.15mg modified-release tablets
0409010W0AAAIAI
|
Pramipexole | Pramipexole | Central Nervous System | 846 |
|
Mirapexin 0.088mg tablets
0409010W0BBACAC
|
Mirapexin | Pramipexole | Central Nervous System | 673 |
|
Pipexus 3.15mg modified-release tablets
0409010W0BEAGAI
|
Pipexus | Pramipexole | Central Nervous System | 608 |
|
Pramipexole 2.62mg modified-release tablets
0409010W0AAAKAK
|
Pramipexole | Pramipexole | Central Nervous System | 595 |
|
Pipexus 2.62mg modified-release tablets
0409010W0BEAFAK
|
Pipexus | Pramipexole | Central Nervous System | 580 |
|
Mirapexin 0.18mg tablets
0409010W0BBABAB
|
Mirapexin | Pramipexole | Central Nervous System | 288 |
|
Mirapexin 1.05mg modified-release tablets
0409010W0BBAGAG
|
Mirapexin | Pramipexole | Central Nervous System | 228 |
|
Mirapexin 0.52mg modified-release tablets
0409010W0BBAFAF
|
Mirapexin | Pramipexole | Central Nervous System | 187 |
|
Mirapexin 2.1mg modified-release tablets
0409010W0BBAHAH
|
Mirapexin | Pramipexole | Central Nervous System | 173 |
|
Mirapexin 1.57mg modified-release tablets
0409010W0BBAJAJ
|
Mirapexin | Pramipexole | Central Nervous System | 170 |
|
Mirapexin 0.26mg modified-release tablets
0409010W0BBAEAE
|
Mirapexin | Pramipexole | Central Nervous System | 158 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.